Status:
COMPLETED
Glycemic Index of Pastry
Lead Sponsor:
Institut Pasteur de Lille
Conditions:
Healthy Volunteers
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
In the early 1980s and following the first publications by Jenkins et al., The notion of glycemic index (GI) appeared with the aim of classifying the different sources of carbohydrates in our diet acc...
Detailed Description
The study will be carried out on healthy volunteers, aged from 18 to 65 with a body mass index (BMI) between 18 and 30 kg/m² (limits included). The main objective of the study is to determine the gly...
Eligibility Criteria
Inclusion
- Man or woman ;
- Aged 18 to 65 (limits included);
- Having a body mass index (BMI) between 18 and 30 kg / m² (limits included);
- Agreeing to maintain their lifestyle (sport and diet) for the duration of the study;
- Agreeing not to smoke on the morning of each visit (before and during the visit).
Exclusion
- Fasting blood glucose ≥ 6.1 mmol / L (or 1.10 g / L);
- Fasting triglycerides ˃ 2 g / L;
- Hyperinsulinemia (20 mIU / L) or history of insulinoma;
- Elevation of transaminases beyond 2x the upper limit;
- Subject presenting episodes of functional post-meal hypoglycaemia;
- Diabetic subject whether or not treated;
- Subject suffering from a severe eating disorder (anorexia, bulimia, binge eating);
- Subject presenting an immunodeficiency or any other serious pathology (cancer, hemopathy);
- Subject with a history of hypercholesterolemia and high blood pressure;
- Subject with renal failure;
- Subject with an allergy / intolerance to one of the constituents of the products under study;
- Subject with an intestinal pathology likely to modify digestion or absorption (Crohn's disease, etc.);
- Subject consuming more than 3 glasses of alcohol per day for men and more than 2 glasses per day for women;
- Subject not having a stable weight for the last 3 months (± 5%);
- Woman pregnant or planning to be during the study period, breastfeeding woman.
Key Trial Info
Start Date :
April 6 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 6 2021
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT05306106
Start Date
April 6 2021
End Date
July 6 2021
Last Update
March 31 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NutrInvest - Institut Pasteur de Lille
Lille, Nord, France, 59019